Johnson & Johnson JNJ, +1.05% stock rose nearly 3% in the extended session Tuesday after the company said it was setting aside $8.9 billion to settle claims connected with cosmetic-talc litigation.
9 billion, payable over 25 years, to resolve “all the current and future talc claims.” That’s an increase of $6.9 billion over the $2 billion previously committed in connection with LTL’s initial bankruptcy filing in October 2021, the company said.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: